NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma

Autores
Brennan, Kevin; Shin, June Ho; Tay, Joshua K.; Prunello, Marcos Miguel; Gentles, Andrew J.; Sunwoo, John B.; Gevaert, Olivier
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Chromatin modifying enzymes are frequently mutated in cancer, resulting in widespread epigenetic deregulation. Recent reports indicate that inactivating mutations in the histone methyltransferase NSD1 define an intrinsic subtype of head and neck squamous cell carcinoma (HNSC) that features pronounced DNA hypomethylation. Here, we describe a similar hypomethylated subtype of lung squamous cell carcinoma (LUSC) that is enriched for both inactivating mutations and deletions in NSD1. The 'NSD1 subtypes' of HNSC and LUSC are highly correlated at the DNA methylation and gene expression levels, featuring ectopic expression of developmental transcription factors and genes that are also hypomethylated in Sotos syndrome, a congenital disorder caused by germline NSD1 mutations. Further, the NSD1 subtype of HNSC displays an 'immune cold' phenotype characterized by low infiltration of tumor-associated leukocytes, particularly macrophages and CD8+ T cells, as well as low expression of genes encoding the immunotherapy target PD-1 immune checkpoint receptor and its ligands. Using an in vivo model, we demonstrate that NSD1 inactivation results in reduced T cell infiltration into the tumor microenvironment, implicating NSD1 as a tumor cell-intrinsic driver of an immune cold phenotype. NSD1 inactivation therefore causes epigenetic deregulation across cancer sites, and has implications for immunotherapy.
Fil: Brennan, Kevin. University of Stanford; Estados Unidos
Fil: Shin, June Ho. University of Stanford; Estados Unidos
Fil: Tay, Joshua K.. National University Health System; Singapur. University of Stanford; Estados Unidos
Fil: Prunello, Marcos Miguel. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Gentles, Andrew J.. University of Stanford; Estados Unidos
Fil: Sunwoo, John B.. University of Stanford; Estados Unidos
Fil: Gevaert, Olivier. University of Stanford; Estados Unidos
Materia
CANCER GENOMICS
DNA METHYLATION
HEAD AND NECK CANCER
IMMUNE EVASION
IMMUNOTHERAPY
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/50389

id CONICETDig_91d7e149232372dc61e4b303c1bc5fb4
oai_identifier_str oai:ri.conicet.gov.ar:11336/50389
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinomaBrennan, KevinShin, June HoTay, Joshua K.Prunello, Marcos MiguelGentles, Andrew J.Sunwoo, John B.Gevaert, OlivierCANCER GENOMICSDNA METHYLATIONHEAD AND NECK CANCERIMMUNE EVASIONIMMUNOTHERAPYhttps://purl.org/becyt/ford/1.2https://purl.org/becyt/ford/1Chromatin modifying enzymes are frequently mutated in cancer, resulting in widespread epigenetic deregulation. Recent reports indicate that inactivating mutations in the histone methyltransferase NSD1 define an intrinsic subtype of head and neck squamous cell carcinoma (HNSC) that features pronounced DNA hypomethylation. Here, we describe a similar hypomethylated subtype of lung squamous cell carcinoma (LUSC) that is enriched for both inactivating mutations and deletions in NSD1. The 'NSD1 subtypes' of HNSC and LUSC are highly correlated at the DNA methylation and gene expression levels, featuring ectopic expression of developmental transcription factors and genes that are also hypomethylated in Sotos syndrome, a congenital disorder caused by germline NSD1 mutations. Further, the NSD1 subtype of HNSC displays an 'immune cold' phenotype characterized by low infiltration of tumor-associated leukocytes, particularly macrophages and CD8+ T cells, as well as low expression of genes encoding the immunotherapy target PD-1 immune checkpoint receptor and its ligands. Using an in vivo model, we demonstrate that NSD1 inactivation results in reduced T cell infiltration into the tumor microenvironment, implicating NSD1 as a tumor cell-intrinsic driver of an immune cold phenotype. NSD1 inactivation therefore causes epigenetic deregulation across cancer sites, and has implications for immunotherapy.Fil: Brennan, Kevin. University of Stanford; Estados UnidosFil: Shin, June Ho. University of Stanford; Estados UnidosFil: Tay, Joshua K.. National University Health System; Singapur. University of Stanford; Estados UnidosFil: Prunello, Marcos Miguel. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Gentles, Andrew J.. University of Stanford; Estados UnidosFil: Sunwoo, John B.. University of Stanford; Estados UnidosFil: Gevaert, Olivier. University of Stanford; Estados UnidosNature Publishing Group2017-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/50389Brennan, Kevin; Shin, June Ho; Tay, Joshua K.; Prunello, Marcos Miguel; Gentles, Andrew J.; et al.; NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma; Nature Publishing Group; Scientific Reports; 7; 1; 12-2017; 1-122045-2322CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-017-17298-xinfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/s41598-017-17298-xinfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:21:29Zoai:ri.conicet.gov.ar:11336/50389instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:21:29.709CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
title NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
spellingShingle NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Brennan, Kevin
CANCER GENOMICS
DNA METHYLATION
HEAD AND NECK CANCER
IMMUNE EVASION
IMMUNOTHERAPY
title_short NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
title_full NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
title_fullStr NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
title_full_unstemmed NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
title_sort NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
dc.creator.none.fl_str_mv Brennan, Kevin
Shin, June Ho
Tay, Joshua K.
Prunello, Marcos Miguel
Gentles, Andrew J.
Sunwoo, John B.
Gevaert, Olivier
author Brennan, Kevin
author_facet Brennan, Kevin
Shin, June Ho
Tay, Joshua K.
Prunello, Marcos Miguel
Gentles, Andrew J.
Sunwoo, John B.
Gevaert, Olivier
author_role author
author2 Shin, June Ho
Tay, Joshua K.
Prunello, Marcos Miguel
Gentles, Andrew J.
Sunwoo, John B.
Gevaert, Olivier
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv CANCER GENOMICS
DNA METHYLATION
HEAD AND NECK CANCER
IMMUNE EVASION
IMMUNOTHERAPY
topic CANCER GENOMICS
DNA METHYLATION
HEAD AND NECK CANCER
IMMUNE EVASION
IMMUNOTHERAPY
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.2
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Chromatin modifying enzymes are frequently mutated in cancer, resulting in widespread epigenetic deregulation. Recent reports indicate that inactivating mutations in the histone methyltransferase NSD1 define an intrinsic subtype of head and neck squamous cell carcinoma (HNSC) that features pronounced DNA hypomethylation. Here, we describe a similar hypomethylated subtype of lung squamous cell carcinoma (LUSC) that is enriched for both inactivating mutations and deletions in NSD1. The 'NSD1 subtypes' of HNSC and LUSC are highly correlated at the DNA methylation and gene expression levels, featuring ectopic expression of developmental transcription factors and genes that are also hypomethylated in Sotos syndrome, a congenital disorder caused by germline NSD1 mutations. Further, the NSD1 subtype of HNSC displays an 'immune cold' phenotype characterized by low infiltration of tumor-associated leukocytes, particularly macrophages and CD8+ T cells, as well as low expression of genes encoding the immunotherapy target PD-1 immune checkpoint receptor and its ligands. Using an in vivo model, we demonstrate that NSD1 inactivation results in reduced T cell infiltration into the tumor microenvironment, implicating NSD1 as a tumor cell-intrinsic driver of an immune cold phenotype. NSD1 inactivation therefore causes epigenetic deregulation across cancer sites, and has implications for immunotherapy.
Fil: Brennan, Kevin. University of Stanford; Estados Unidos
Fil: Shin, June Ho. University of Stanford; Estados Unidos
Fil: Tay, Joshua K.. National University Health System; Singapur. University of Stanford; Estados Unidos
Fil: Prunello, Marcos Miguel. Universidad Nacional de Rosario. Facultad de Ciencias Bioquímicas y Farmacéuticas; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Gentles, Andrew J.. University of Stanford; Estados Unidos
Fil: Sunwoo, John B.. University of Stanford; Estados Unidos
Fil: Gevaert, Olivier. University of Stanford; Estados Unidos
description Chromatin modifying enzymes are frequently mutated in cancer, resulting in widespread epigenetic deregulation. Recent reports indicate that inactivating mutations in the histone methyltransferase NSD1 define an intrinsic subtype of head and neck squamous cell carcinoma (HNSC) that features pronounced DNA hypomethylation. Here, we describe a similar hypomethylated subtype of lung squamous cell carcinoma (LUSC) that is enriched for both inactivating mutations and deletions in NSD1. The 'NSD1 subtypes' of HNSC and LUSC are highly correlated at the DNA methylation and gene expression levels, featuring ectopic expression of developmental transcription factors and genes that are also hypomethylated in Sotos syndrome, a congenital disorder caused by germline NSD1 mutations. Further, the NSD1 subtype of HNSC displays an 'immune cold' phenotype characterized by low infiltration of tumor-associated leukocytes, particularly macrophages and CD8+ T cells, as well as low expression of genes encoding the immunotherapy target PD-1 immune checkpoint receptor and its ligands. Using an in vivo model, we demonstrate that NSD1 inactivation results in reduced T cell infiltration into the tumor microenvironment, implicating NSD1 as a tumor cell-intrinsic driver of an immune cold phenotype. NSD1 inactivation therefore causes epigenetic deregulation across cancer sites, and has implications for immunotherapy.
publishDate 2017
dc.date.none.fl_str_mv 2017-12
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/50389
Brennan, Kevin; Shin, June Ho; Tay, Joshua K.; Prunello, Marcos Miguel; Gentles, Andrew J.; et al.; NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma; Nature Publishing Group; Scientific Reports; 7; 1; 12-2017; 1-12
2045-2322
CONICET Digital
CONICET
url http://hdl.handle.net/11336/50389
identifier_str_mv Brennan, Kevin; Shin, June Ho; Tay, Joshua K.; Prunello, Marcos Miguel; Gentles, Andrew J.; et al.; NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma; Nature Publishing Group; Scientific Reports; 7; 1; 12-2017; 1-12
2045-2322
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1038/s41598-017-17298-x
info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/s41598-017-17298-x
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614203319517184
score 13.070432